Skip to main content
Block #9

NVO · NYSE

Novo Nordisk stock price

Danish pharma group behind Ozempic and Wegovy.

Price

-

Exchange

NYSE

Sector

Healthcare

Denemarken

Price trend

1 day to 5 years

-30 days

Loading price data…

1D
-
7D
-
30D
-
60D
-
180D
-
1J
-
5J
-

All amounts converted to euro at the daily FX rate. Indicative and delayed.

About the company

NVO · Denemarken

Novo Nordisk logo

Novo Nordisk (NVO) trades on NYSE out of Denemarken within healthcare. Danish pharma group behind Ozempic and Wegovy.

  • #Ticker NVO on NYSE
  • #Sector: Healthcare · headquartered in Denemarken
  • #Prices on this page are indicative and delayed
  • #Editorial explanation, not investment advice
Ticker
NVO
Exchange
NYSE
Country
Denemarken
Sector
Healthcare

Indicative, delayed price. Editorial explanation, not investment advice.

Background & analysis

By the Block #9 newsroom

What does Novo Nordisk do?

Novo Nordisk is listed on NYSE and operates in healthcare. Danish pharma group behind Ozempic and Wegovy. Revenue comes from the core activity described above; the company reports quarterly and publishes guidance alongside it.

What moves the share price?

The Novo Nordisk share moves mainly on quarterly results, management guidance and sentiment across healthcare. Macro data from Denemarken and the euro exchange rate matter too for European investors.

In healthcare it is all about the pipeline: approvals, patent cliffs and reimbursement decisions drive valuation.

Risks to watch

Every share carries company-specific risk: competition, margin pressure and regulation. On top of that comes market risk, a broad correction drags good companies down too.

Numbers to watch each quarter at Novo Nordisk

At Novo Nordisk every quarterly report comes down to three things: year-on-year revenue growth, the operating margin and the guidance management provides. That guidance often moves the share more than the reported numbers, because the market has been trading on an expectation for months.

Also watch free cash flow and what the company does with it: repaying debt, buying back stock, paying a dividend or investing in growth. For a company in healthcare that choice says a lot about how management sees the coming years.

Novo Nordisk compared with peers

A share price on its own says little. Put NVO next to other names in healthcare, six are listed further down this page, and compare growth, margin and valuation. A share that looks expensive can be rightly expensive when growth is structurally higher; a low valuation is often a sign the market doubts the business model.

What does this mean for a European investor?

All amounts on this page are shown in euro. If Novo Nordisk is quoted in another currency we convert at the daily rate. That also means your return has two parts: the move in the share itself and the exchange rate. A 10% gain in dollars can be materially smaller in euro when the dollar weakens at the same time.

Keep the tax side in mind too: transaction taxes, withholding on dividends and possibly source tax in the country of listing (Denemarken). Those costs weigh more heavily the more often you trade.

How to read this page

The top of the page shows the latest known price with the daily move. The chart below runs from one day to five years: pick a period, hover the line and you see the price at that moment. Returns per period sit in the strip below the chart.

The chart shows direction and volatility, not a forecast. Prices are indicative and may be delayed; always use your broker's data before placing an order.

Frequently asked questions

Novo Nordisk

Where is Novo Nordisk listed?

Novo Nordisk trades under ticker NVO on NYSE, with headquarters in Denemarken.

How does Novo Nordisk make money?

Novo Nordisk is listed on NYSE and operates in healthcare. Danish pharma group behind Ozempic and Wegovy. Revenue comes from the core activity described above; the company reports quarterly and publishes guidance alongside it.

What moves the NVO share most?

The Novo Nordisk share moves mainly on quarterly results, management guidance and sentiment across healthcare. Macro data from Denemarken and the euro exchange rate matter too for European investors.

What are the main risks at Novo Nordisk?

Every share carries company-specific risk: competition, margin pressure and regulation. On top of that comes market risk, a broad correction drags good companies down too.

Which currency is the Novo Nordisk price shown in?

Euro. If the share is quoted in another currency we convert at the daily rate, so your return also depends on FX.

Which shares are similar to Novo Nordisk?

Peers from healthcare are listed at the bottom of this page under "Similar stocks". Compare growth, margin and valuation before drawing conclusions.

Are the prices on this page live?

Prices are indicative and may be delayed. Use your broker's data before placing an order.

Is this investment advice?

No. Block #9 explains how a company works and what moves its share. You make the decision yourself.

Similar stocks

Healthcare

All stock prices